Resolution of inflammation: Examples of peptidergic players and pathways

Drug Discovery Today

Volumn 19, Issue 8, 2014, Pages 1166-1171

  Ahmed, Tazeen J ^a   Kaneva, Magdalena K ^a   Pitzalis, Costantino ^a   Cooper, Dianne ^a   Perretti, Mauro ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GALECTIN; MELANOCORTIN RECEPTOR; PROOPIOMELANOCORTIN; ANTIINFLAMMATORY AGENT; PEPTIDE;

APOPTOSIS; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; INTRACELLULAR SPACE; LEUKOCYTE MIGRATION; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SKIN FIBROBLAST; SPLEEN CELL; ULCERATIVE COLITIS; UPREGULATION; ANIMAL; DRUG DEVELOPMENT; DRUG EFFECTS; PROCEDURES; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DRUG DISCOVERY; HUMANS; INFLAMMATION; PEPTIDES; SIGNAL TRANSDUCTION;

EID: 84906310432     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.05.020     Document Type: Review

References (45)

1. C.N. Serhan The resolution of inflammation: the devil in the flask and in the details FASEB J. 25 2011 1441 1448
2. A.M. Smith et al. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease J. Exp. Med. 206 2009 1883 1897
3. P. Maderna, and C. Godson Lipoxins: resolutionary road Br. J. Pharmacol. 158 2009 947 959
4. 4 and annexin-derived peptide-stimulated phagocytosis FASEB J. 24 2010 4240 4249
5. Y. Liu et al. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes J. Immunol. 162 1999 3639 3646
6. M. Spite et al. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis Nature 461 2009 1287 1291
7. F. D'Acquisto On the adaptive nature of annexin-A1 Curr. Opin. Pharmacol. 9 2009 521 528
8. J.M. Schwab et al. Resolvin E1 and protectin D1 activate inflammation-resolution programmes Nature 447 2007 869 874
9. S.M. Rankin The bone marrow: a site of neutrophil clearance J. Leukoc. Biol. 88 2010 241 251
10. J. Dalli et al. Annexin A1 regulates neutrophil clearance by macrophages in the mouse bone marrow FASEB J. 26 2012 387 396
11. K. Starowicz, and B. Przewlocka The role of melanocortins and their receptors in inflammatory processes, nerve regeneration and nociception Life Sci. 73 2003 823 847
12. A. Slominski, and J. Wortsman Neuroendocrinology of the skin Endocr. Rev. 21 2000 457 487
13. D.J. Lee et al. Injection of an alpha-melanocyte stimulating hormone expression plasmid is effective in suppressing experimental autoimmune uveitis Int. Immunopharmacol. 9 2009 1079 1086
14. C. Lam et al. Melanocortin receptor signaling in RAW264.7 macrophage cell line Peptides 27 2006 404 412
15. S. Grassel et al. The melanocortin system in articular chondrocytes: melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of alpha-melanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components Arthritis Rheum. 60 2009 3017 3027
16. A. Catania et al. The anticytokine neuropeptide alpha-melanocyte- stimulating hormone in synovial fluid of patients with rheumatic diseases: comparisons with other anticytokine molecules Neuroimmunomodulation 1 1994 321 328
17. S. Getting et al. Melanocortin 3 receptors control crystal-induced inflammation FASEB J. 20 2006 2234 2241
18. H.B. Patel et al. Anti-inflammatory and antiosteoclastogenesis properties of endogenous melanocortin receptor type 3 in experimental arthritis FASEB J. 12 2010 4835 4843
19. T. Montero-Melendez et al. The melanocortin agonist AP214 exerts anti-inflammatory and proresolving properties Am. J. Pathol. 179 2011 259 269
20. J. Kristensen et al. The alpha-MSH analogue AP214 attenuates rise in pulmonary pressure and fall in ejection fraction in lipopolysaccharide-induced systemic inflammatory response syndrome in pigs Clin. Physiol. Funct. Imaging 31 2011 54 60
21. K. Doi et al. AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality Kidney Int. 73 2008 1266 1274
22. M.N. Simmons et al. Alpha-melanocyte stimulating hormone analogue AP214 protects against ischemia induced acute kidney injury in a porcine surgical model J. Urol. 183 2010 1625 1629
23. A. Ottani et al. Melanocortins counteract inflammatory and apoptotic responses to prolonged myocardial ischemia/reperfusion through a vagus nerve-mediated mechanism Eur. J. Pharmacol. 637 2010 124 130
24. P.M. Holloway et al. Targeting the melanocortin receptor system for anti-stroke therapy Trends Pharmacol. Sci. 32 2011 90 98
25. S. Getting et al. A role for MC3R in modulating lung inflammation Pulm. Pharmacol. Ther. 21 2008 866 873
26. U. Raap et al. Alpha-melanocyte-stimulating hormone inhibits allergic airway inflammation J. Immunol. 171 2003 353 359
27. S.N. Lee et al. α-Melanocyte-stimulating hormone inhibits tumor necrosis factor alpha-stimulated MUC5AC expression in human nasal epithelial cells Am. J. Respir. Cell Mol. Biol. 44 2011 716 724
28. M. Artuc et al. Human mast cells in the neurohormonal network: expression of POMC, detection of precursor proteases, and evidence for IgE-dependent secretion of alpha-MSH J. Invest. Dermatol. 126 2006 1976 1981
29. L.A. Muffley et al. Spatial and temporal localization of the melanocortin 1 receptor and its ligand alpha-melanocyte-stimulating hormone during cutaneous wound repair J. Histochem. Cytochem. 59 2011 278 288
30. S. Di Lella et al. When galectins recognize glycans: from biochemistry to physiology and back again Biochemistry 50 2011 7842 7857
31. M. Seki et al. Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts Arthritis Rheum. 56 2007 3968 3976
32. S. Ohshima et al. Galectin 3 and its binding protein in rheumatoid arthritis Arthritis Rheum. 48 2003 2788 2795
33. A.J. Iqbal et al. Endogenous galectin-1 and acute inflammation: emerging notion of a galectin-9 pro-resolving effect Am. J. Pathol. 178 2011 1201 1209
34. J.M. Ilarregui et al. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10 Nat. Immunol. 10 2009 981 991
35. M.A. Toscano et al. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death Nat. Immunol. 8 2007 825 834
36. M. Seki et al. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis Clin. Immunol. 127 2008 78 88
37. G.A. Rabinovich et al. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis J. Exp. Med. 190 1999 385 398
38. M.I. Garin et al. Galectin-1: a key effector of regulation mediated by CD4+ CD25+ T cells Blood 109 2007 2058 2065
39. D. Cooper et al. Novel insights into the inhibitory effects of Galectin-1 on neutrophil recruitment under flow J. Leukoc. Biol. 83 2008 1459 1466
40. L.V. Norling et al. Inhibitory control of endothelial galectin-1 on in vitro and in vivo lymphocyte trafficking FASEB J. 22 2008 682 690
41. J. He, and L.G. Baum Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration Lab. Invest. 86 2006 578 590
42. C. Zhu et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity Nat. Immunol. 6 2005 1245 1252
43. M. Pang et al. CD45-mediated fodrin cleavage during galectin-1 T cell death promotes phagocytic clearance of dying cells J. Immunol. 182 2009 7001 7008
44. S.R. Stowell et al. Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion J. Immunol. 180 2008 3091 3102
45. F. Cedeno-Laurent et al. Development of a nascent galectin-1 chimeric molecule for studying the role of leukocyte galectin-1 ligands and immune disease modulation J. Immunol. 185 2010 4659 4672